Dr Chris Vaughan

Clinical Senior Lecturer
Medicine, Northern Clinical School
Kolling Institute of Medical Research

Telephone 9926 4950
Fax 9906 4079

Map

PhD and master's project opportunities

Selected grants

2014

  • Spinal analgesic mechanisms of GABA and glycine transport blockers in neuropathic pain states; Vaughan C; DVC Research/Bridging Support Grant.

2013

  • Opiod-cannabinoid interactions in midbrain analgesic pathways; Vaughan C; DVC Research/Bridging Support Grant.

2011

  • Endocannabinoid-TRP interactions in midbrain analgesic pathways; Vaughan C, Drew G; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Molecular targets of amino acid/neurotransmitter conjugates of fatty acids; Connor M, Vaughan C, Kassiou M, McIntyre P; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Mechanisms of serotonergic and triptan mediated analgesia within the midbrain; Vaughan C, Connor M, Jeong H; National Health and Medical Research Council (NHMRC)/Project Grants.

2008

  • Real-time cellular imaging system; Connor M, Keast J, Vaughan C, Christie M, Osborne P, Bagley E, Sue C; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Effects of muscle inflammation on sensory neuron excitability; Connor M, Vaughan C; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Cellular mechanisms of endogenous cannabinoid mediated analgesia within the midbrain.; Vaughan C; National Health and Medical Research Council (NHMRC)/Project Grants.

2006

  • Molecular and cellular basis for the analgesic properties of N-arachidynyl amino acids; Vandenberg R, Connor M, Vaughan C; National Health and Medical Research Council (NHMRC)/Project Grants.

2004

  • Cellular actions of cannabinoids within the spinal cord dorsal horn in a neuropathic pain state; Vaughan C; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Olympus FV300 confocal system plus assessories; Christie M, Vaughan C, Connor M, Keay K; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2002

  • ANZCA Research Grant; Wrigley P, Vaughan C; ANZ Coll Anaesthetists (ANZCA)/Research Funding Scheme.

2001

  • Cellular mechanisms of cannabinoid analgesia; Vaughan C; National Health and Medical Research Council (NHMRC)/Project Grants.

2000

  • Cellular mechanism of opioid physical dependence; Vaughan C, Christie M; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Cellular mechanisms of cannabinoid analgesia; Vaughan C; University of Sydney/University Research Grant.
  • Cellular mechanisms of opioid physical dependence; Vaughan C; National Health and Medical Research Council (NHMRC)/Early Career Fellowships (ECF).

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Vaughan, C., Drew, G. (2007). Cellular actions of cannabinoids and opioids in descending analgesic systems. In Sabatino Maione, Vincenzo Di Marzo (Eds.), Neurotransmitters in the Antinociceptive Descending Pathways, (pp. 83-96). Kerala: Research Signpost.
  • Wessendorf, M., Vaughan, C., Vanegas, H. (2006). Rethinking the PAG and RVM: Supraspinal modulation of nociception by opioids and non-opioids. In H Flor, E Kalso, Dostrovsky JO (Eds.), Proceedings of the 11th World Congress on Pain, (pp. 311-320). Seattle: IASP PRESS.
  • Vaughan, C., Christie, M. (2005). Mechanisms of cannabinoid analgesia. Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential, (pp. 89-100). UK: Harworth Press.
  • Vaughan, C., Christie, M. (2005). Retrograde signalling by endocannabinoids. In Pertwee R (Eds.), Handbook of Experimental Pharmacology, (pp. 367-384). Heidelberg: Springer.
  • Christie, M., Vaughan, C. (2004). Mechanismen Der Cannabinoidanalgesie. In Franjo Grotenhermen (Eds.), Cannabis und Cannabinoide, (pp. 115-125). Bern: Nicholson Museum, University of Sydney.
  • Vaughan, C., Christie, M. (2002). Mechanisms of Cannabinoid Analgesia. In Grotenhermen, F & Russo, E (Eds.), Cannibis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential, (pp. 89-99). Binghampton, NY, USA: Staempfli Publishers Ltd.
  • Vaughan, C., Christie, M. (2001). Mechanisms of cannabinoid analgesia. In Franjo Grotenhermen (Hrsg) (Eds.), Cannabis and Cannabinoide, (pp. 109-119). Germany: Academic Press Elsevier.

Journals

  • Anderson, B., Gould, M., Torres, R., Mitchell, V., Vaughan, C. (2014). Actions of the dual FAAH/MAGL inhibitor JZL 195 in a murine inflammatory pain model. Neuropharmacology, 81, 224-230. [More Information]
  • Drummond, P., Drummond, E., Dawson, L., Mitchell, V., Finch, P., Vaughan, C., Phillips, J. (2014). Up-regulation of α1-adrenoceptors on cutaneous nerve fibres after partial sciatic nerve ligation and in complex regional pain syndrome type II. Pain, 155(3), 606-610. [More Information]
  • Wilson-Poe, A., Mitchell, V., Vaughan, C. (2013). Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey. Neuropharmacology, 66, 348-354. [More Information]
  • Soiza-Reilly, M., Anderson, B., Vaughan, C., Commons, K. (2013). Presynaptic gating of excitation in the dorsal raphe nucleus by GABA. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 110(39), 15800-15805. [More Information]
  • Jeong, H., Lam, K., Mitchell, V., Vaughan, C. (2013). Serotonergic modulation of neuronal activity in rat midbrain periaqueductal grey. Journal of Neurophysiology, 109, 2712-2719. [More Information]
  • Jayamanne, A., Jeong, H., Schroeder, C., Lewis, R., Christie, M., Vaughan, C. (2013). Spinal actions of omega-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model. British Journal of Pharmacology, 170(2), 245-254. [More Information]
  • Jeong, H., Mitchell, V., Vaughan, C. (2012). Role of 5-HT1 receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn. British Journal of Pharmacology, 165(6), 1956-1965. [More Information]
  • Klimis, H., Adams, D., Callaghan, B., Nevin, S., Alewood, P., Vaughan, C., Mozar, C., Christie, M. (2011). A Novel Mechanism of Inhibition of High-Voltage Activated Calcium Channels by alpha-Conotoxins Contributes to Relief of Nerve Injury-Induced Neuropathic Pain. Pain, 152(2), 259-266. [More Information]
  • Mitchell, V., Jeong, H., Drew, G., Vaughan, C. (2011). Cholecystokinin Exerts an Effect via the Endocannabinoid System to Inhibit GABAergic Transmission in Midbrain Periaqueductal Gray. Neuropsychopharmacology, 36(9), 1801-1810. [More Information]
  • Kawahara, H., Drew, G., Christie, M., Vaughan, C. (2011). Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. British Journal of Pharmacology, 163(6), 1214-1222. [More Information]
  • Pedersen, N., Vaughan, C., Christie, M. (2011). Opioid receptor modulation of GABAergic and serotonergic spinally-projecting neurons of the rostral ventromedial medulla in mice. Journal of Neurophysiology, 106(2), 731-740. [More Information]
  • Christie, M., Vaughan, C. (2011). Receptors: Cannabis medicine without a high. Nature Chemical Biology. [More Information]
  • Wrigley, P., Jeong, H., Vaughan, C. (2010). Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Molecular Pain, 6(1), 1-10. [More Information]
  • Connor, M., Vaughan, C., Vandenberg, R. (2010). N-Acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. British Journal of Pharmacology, 160(8), 1857-1871. [More Information]
  • Jeong, H., Vandenberg, R., Vaughan, C. (2010). N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. British Journal of Pharmacology, 161(4), 925-935. [More Information]
  • Mitchell, V., Kawahara, H., Vaughan, C. (2009). Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey. The Journal of Physiology, 587(11), 2511-2520. [More Information]
  • Wrigley, P., Jeong, H., Vaughan, C. (2009). Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurons. British Journal of Pharmacology, 157, 371-380. [More Information]
  • Drew, G., Lau, B., Vaughan, C. (2009). Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. The Journal of Neuroscience, 29(22), 7220-7229. [More Information]
  • Vuong, L., Mitchell, V., Vaughan, C. (2008). Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology, 54(1), 189-193. [More Information]
  • Drew, G., Mitchell, V., Vaughan, C. (2008). Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. The Journal of Neuroscience, 28(4), 808-815. [More Information]
  • Lau, B., Vaughan, C. (2008). Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Molecular Pharmacology, 74(5), 1392-1398. [More Information]
  • Jeong, H., Chenu, D., Johnson, E., Connor, M., Vaughan, C. (2008). Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular Pain, 4(54), 1-11. [More Information]
  • Succar, R., Mitchell, V., Vaughan, C. (2007). Actions of N-arachidonyl-glycine in a rat inflammatory pain model. Molecular Pain, 3, 24-24. [More Information]
  • Mitchell, V., Greenwood, R., Jayamanne, A., Vaughan, C. (2007). Actions of the endocannabinoid transport inhibitor am404 in neuropathic and inflammatory pain models. Clinical and Experimental Pharmacology and Physiology, 34(11), 1186-1190. [More Information]
  • Jayamanne, A., Greenwood, R., Mitchell, V., Aslan, S., Piomelli, D., Vaughan, C. (2006). Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. British Journal of Pharmacology, 147(3), 281-288. [More Information]
  • Vaughan, C. (2006). Stressed-out endogenous cannabinoids relieve pain. Trends In Pharmacological Sciences, 27(2), 69-71. [More Information]
  • Ekberg, J., Jayamanne, A., Vaughan, C., Aslan, S., Thomas, L., Mould, J., Drinkwater, R., Baker, M., Abrahamsen, B., Wood, J., Christie, M., et al (2006). {micro}O-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 103(45), 17030-17035. [More Information]
  • Marinelli, S., Connor, M., Schnell, S., Christie, M., Wessendorf, M., Vaughan, C. (2005). delta-OPIOID RECEPTOR-MEDIATED ACTIONS ON ROSTRAL VENTROMEDIAL MEDULLA NEURONS. Neuroscience, 132(2), 239-244. [More Information]
  • Mitchell, V., Aslan, S., Safaei, R., Vaughan, C. (2005). Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain. Neuroscience Letters, 382(3), 231-235. [More Information]
  • Bagley, E., Gerke, M., Vaughan, C., Hack, S., Christie, M. (2005). GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron, 45(3), 433-445. [More Information]
  • Connor, M., Vaughan, C. (2005). Humanizing mice: catching up with elusive B1 receptors. British Journal of Pharmacology, 144(7), 885-6. [More Information]
  • Vaughan, C., Drew, G., Mitchell, V. (2005). Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology. [More Information]
  • Gavioli, E., Vaughan, C., Marzola, G., Guerrini, R., Mitchell, V., Zucchini, S., De Lima, T., Rae, G., Salvadori, S., Regoli, D., et al (2004). Antidepressant-Like Effects Of The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101: New Evidence From Rats And Mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 369(6), 547-553. [More Information]
  • Connor, M., Bagley, E., Mitchell, V., Ingram, S., Christie, M., Humphrey, P., Vaughan, C. (2004). Cellular Actions Of Somatostatin On Rat Periaqueductal Grey Neurons In Vitro. British Journal of Pharmacology, 142(8), 1273-1280.
  • Drew, G., Vaughan, C. (2004). Multiple Metabotropic Glutamate Receptor Subtypes Modulate Gabaergic Neurotransmission In Rat Periaqueductal Grey Neurons In Vitro. Neuropharmacology, 46(7), 927-934.
  • Marinelli, S., Schnell, S., Hack, S., Christie, M., Wessendorf, M., Vaughan, C. (2004). Serotonergic And Nonserotonergic Dorsal Raphe Neurons Are Pharmacologically And Electrophysiologically Heterogeneous. Journal of Neurophysiology, 92(6), 3532-3537.
  • Mitchell, V., Christie, M., Vaughan, C. (2003). Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons. NeuroReport, 14(12), 1637-1639.
  • Vaughan, C., Connor, M. (2003). In search of a role for the morphine metabolite morphine-3-glucuronide. Anesthesia and Analgesia, 97(2), 311-312.
  • Hack, S., Vaughan, C., Christie, M. (2003). Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology, 45(5), 575-584.
  • Jennings, E., Vaughan, C., Roberts, L., Christie, M. (2003). The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. The Journal of Physiology, 548(1), 121-129.
  • Marinelli, S., Vaughan, C., Schnell, S., Wessendorf, M., Christie, M. (2002). Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. The Journal of Neuroscience, 22(24), 10847-10855.
  • Vaughan, C., Connor, M., Jennings, E., Marinelli, S., Christie, M., Allen, R. (2001). Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. The Journal of Physiology, 534, 849-859.
  • Jennings, E., Vaughan, C., Christie, M. (2001). Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. The Journal of Physiology, 534, 805-812.

Conferences

  • Wrigley, P., Vaughan, C. (2005). Spinal mechanisms of thermal nociceptive processing. International Association for the Study of Pain (IASP) 11th World Congress on Pain, 2005, Australia: International Association for the Study of Pain Press.
  • Wrigley, P., Vaughan, C. (2002). Cold afferent inputs activate a subpopulation of rat dorsal horn neurons in vitro. Australian Neuroscience Society Annual Meeting, Australia: British Medical Journal Publishing Group.
  • Wrigley, P., Vaughan, C. (2002). Spinal cord processing of nociceptive inputs. University of Technology Sydney XIXth Scientific Research Meeting/University of Technology Sydney XIXth Scientific Research Meeting.

2014

  • Anderson, B., Gould, M., Torres, R., Mitchell, V., Vaughan, C. (2014). Actions of the dual FAAH/MAGL inhibitor JZL 195 in a murine inflammatory pain model. Neuropharmacology, 81, 224-230. [More Information]
  • Drummond, P., Drummond, E., Dawson, L., Mitchell, V., Finch, P., Vaughan, C., Phillips, J. (2014). Up-regulation of α1-adrenoceptors on cutaneous nerve fibres after partial sciatic nerve ligation and in complex regional pain syndrome type II. Pain, 155(3), 606-610. [More Information]

2013

  • Wilson-Poe, A., Mitchell, V., Vaughan, C. (2013). Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey. Neuropharmacology, 66, 348-354. [More Information]
  • Soiza-Reilly, M., Anderson, B., Vaughan, C., Commons, K. (2013). Presynaptic gating of excitation in the dorsal raphe nucleus by GABA. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 110(39), 15800-15805. [More Information]
  • Jeong, H., Lam, K., Mitchell, V., Vaughan, C. (2013). Serotonergic modulation of neuronal activity in rat midbrain periaqueductal grey. Journal of Neurophysiology, 109, 2712-2719. [More Information]
  • Jayamanne, A., Jeong, H., Schroeder, C., Lewis, R., Christie, M., Vaughan, C. (2013). Spinal actions of omega-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model. British Journal of Pharmacology, 170(2), 245-254. [More Information]

2012

  • Jeong, H., Mitchell, V., Vaughan, C. (2012). Role of 5-HT1 receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn. British Journal of Pharmacology, 165(6), 1956-1965. [More Information]

2011

  • Klimis, H., Adams, D., Callaghan, B., Nevin, S., Alewood, P., Vaughan, C., Mozar, C., Christie, M. (2011). A Novel Mechanism of Inhibition of High-Voltage Activated Calcium Channels by alpha-Conotoxins Contributes to Relief of Nerve Injury-Induced Neuropathic Pain. Pain, 152(2), 259-266. [More Information]
  • Mitchell, V., Jeong, H., Drew, G., Vaughan, C. (2011). Cholecystokinin Exerts an Effect via the Endocannabinoid System to Inhibit GABAergic Transmission in Midbrain Periaqueductal Gray. Neuropsychopharmacology, 36(9), 1801-1810. [More Information]
  • Kawahara, H., Drew, G., Christie, M., Vaughan, C. (2011). Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. British Journal of Pharmacology, 163(6), 1214-1222. [More Information]
  • Pedersen, N., Vaughan, C., Christie, M. (2011). Opioid receptor modulation of GABAergic and serotonergic spinally-projecting neurons of the rostral ventromedial medulla in mice. Journal of Neurophysiology, 106(2), 731-740. [More Information]
  • Christie, M., Vaughan, C. (2011). Receptors: Cannabis medicine without a high. Nature Chemical Biology. [More Information]

2010

  • Wrigley, P., Jeong, H., Vaughan, C. (2010). Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Molecular Pain, 6(1), 1-10. [More Information]
  • Connor, M., Vaughan, C., Vandenberg, R. (2010). N-Acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. British Journal of Pharmacology, 160(8), 1857-1871. [More Information]
  • Jeong, H., Vandenberg, R., Vaughan, C. (2010). N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. British Journal of Pharmacology, 161(4), 925-935. [More Information]

2009

  • Mitchell, V., Kawahara, H., Vaughan, C. (2009). Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey. The Journal of Physiology, 587(11), 2511-2520. [More Information]
  • Wrigley, P., Jeong, H., Vaughan, C. (2009). Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurons. British Journal of Pharmacology, 157, 371-380. [More Information]
  • Drew, G., Lau, B., Vaughan, C. (2009). Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. The Journal of Neuroscience, 29(22), 7220-7229. [More Information]

2008

  • Vuong, L., Mitchell, V., Vaughan, C. (2008). Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology, 54(1), 189-193. [More Information]
  • Drew, G., Mitchell, V., Vaughan, C. (2008). Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. The Journal of Neuroscience, 28(4), 808-815. [More Information]
  • Lau, B., Vaughan, C. (2008). Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Molecular Pharmacology, 74(5), 1392-1398. [More Information]
  • Jeong, H., Chenu, D., Johnson, E., Connor, M., Vaughan, C. (2008). Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular Pain, 4(54), 1-11. [More Information]

2007

  • Succar, R., Mitchell, V., Vaughan, C. (2007). Actions of N-arachidonyl-glycine in a rat inflammatory pain model. Molecular Pain, 3, 24-24. [More Information]
  • Mitchell, V., Greenwood, R., Jayamanne, A., Vaughan, C. (2007). Actions of the endocannabinoid transport inhibitor am404 in neuropathic and inflammatory pain models. Clinical and Experimental Pharmacology and Physiology, 34(11), 1186-1190. [More Information]
  • Vaughan, C., Drew, G. (2007). Cellular actions of cannabinoids and opioids in descending analgesic systems. In Sabatino Maione, Vincenzo Di Marzo (Eds.), Neurotransmitters in the Antinociceptive Descending Pathways, (pp. 83-96). Kerala: Research Signpost.

2006

  • Jayamanne, A., Greenwood, R., Mitchell, V., Aslan, S., Piomelli, D., Vaughan, C. (2006). Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. British Journal of Pharmacology, 147(3), 281-288. [More Information]
  • Wessendorf, M., Vaughan, C., Vanegas, H. (2006). Rethinking the PAG and RVM: Supraspinal modulation of nociception by opioids and non-opioids. In H Flor, E Kalso, Dostrovsky JO (Eds.), Proceedings of the 11th World Congress on Pain, (pp. 311-320). Seattle: IASP PRESS.
  • Vaughan, C. (2006). Stressed-out endogenous cannabinoids relieve pain. Trends In Pharmacological Sciences, 27(2), 69-71. [More Information]
  • Ekberg, J., Jayamanne, A., Vaughan, C., Aslan, S., Thomas, L., Mould, J., Drinkwater, R., Baker, M., Abrahamsen, B., Wood, J., Christie, M., et al (2006). {micro}O-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 103(45), 17030-17035. [More Information]

2005

  • Marinelli, S., Connor, M., Schnell, S., Christie, M., Wessendorf, M., Vaughan, C. (2005). delta-OPIOID RECEPTOR-MEDIATED ACTIONS ON ROSTRAL VENTROMEDIAL MEDULLA NEURONS. Neuroscience, 132(2), 239-244. [More Information]
  • Mitchell, V., Aslan, S., Safaei, R., Vaughan, C. (2005). Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain. Neuroscience Letters, 382(3), 231-235. [More Information]
  • Bagley, E., Gerke, M., Vaughan, C., Hack, S., Christie, M. (2005). GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron, 45(3), 433-445. [More Information]
  • Connor, M., Vaughan, C. (2005). Humanizing mice: catching up with elusive B1 receptors. British Journal of Pharmacology, 144(7), 885-6. [More Information]
  • Vaughan, C., Christie, M. (2005). Mechanisms of cannabinoid analgesia. Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential, (pp. 89-100). UK: Harworth Press.
  • Vaughan, C., Drew, G., Mitchell, V. (2005). Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology. [More Information]
  • Vaughan, C., Christie, M. (2005). Retrograde signalling by endocannabinoids. In Pertwee R (Eds.), Handbook of Experimental Pharmacology, (pp. 367-384). Heidelberg: Springer.
  • Wrigley, P., Vaughan, C. (2005). Spinal mechanisms of thermal nociceptive processing. International Association for the Study of Pain (IASP) 11th World Congress on Pain, 2005, Australia: International Association for the Study of Pain Press.

2004

  • Gavioli, E., Vaughan, C., Marzola, G., Guerrini, R., Mitchell, V., Zucchini, S., De Lima, T., Rae, G., Salvadori, S., Regoli, D., et al (2004). Antidepressant-Like Effects Of The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101: New Evidence From Rats And Mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 369(6), 547-553. [More Information]
  • Connor, M., Bagley, E., Mitchell, V., Ingram, S., Christie, M., Humphrey, P., Vaughan, C. (2004). Cellular Actions Of Somatostatin On Rat Periaqueductal Grey Neurons In Vitro. British Journal of Pharmacology, 142(8), 1273-1280.
  • Christie, M., Vaughan, C. (2004). Mechanismen Der Cannabinoidanalgesie. In Franjo Grotenhermen (Eds.), Cannabis und Cannabinoide, (pp. 115-125). Bern: Nicholson Museum, University of Sydney.
  • Drew, G., Vaughan, C. (2004). Multiple Metabotropic Glutamate Receptor Subtypes Modulate Gabaergic Neurotransmission In Rat Periaqueductal Grey Neurons In Vitro. Neuropharmacology, 46(7), 927-934.
  • Marinelli, S., Schnell, S., Hack, S., Christie, M., Wessendorf, M., Vaughan, C. (2004). Serotonergic And Nonserotonergic Dorsal Raphe Neurons Are Pharmacologically And Electrophysiologically Heterogeneous. Journal of Neurophysiology, 92(6), 3532-3537.

2003

  • Mitchell, V., Christie, M., Vaughan, C. (2003). Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons. NeuroReport, 14(12), 1637-1639.
  • Vaughan, C., Connor, M. (2003). In search of a role for the morphine metabolite morphine-3-glucuronide. Anesthesia and Analgesia, 97(2), 311-312.
  • Hack, S., Vaughan, C., Christie, M. (2003). Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology, 45(5), 575-584.
  • Jennings, E., Vaughan, C., Roberts, L., Christie, M. (2003). The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. The Journal of Physiology, 548(1), 121-129.

2002

  • Wrigley, P., Vaughan, C. (2002). Cold afferent inputs activate a subpopulation of rat dorsal horn neurons in vitro. Australian Neuroscience Society Annual Meeting, Australia: British Medical Journal Publishing Group.
  • Vaughan, C., Christie, M. (2002). Mechanisms of Cannabinoid Analgesia. In Grotenhermen, F & Russo, E (Eds.), Cannibis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential, (pp. 89-99). Binghampton, NY, USA: Staempfli Publishers Ltd.
  • Marinelli, S., Vaughan, C., Schnell, S., Wessendorf, M., Christie, M. (2002). Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. The Journal of Neuroscience, 22(24), 10847-10855.
  • Wrigley, P., Vaughan, C. (2002). Spinal cord processing of nociceptive inputs. University of Technology Sydney XIXth Scientific Research Meeting/University of Technology Sydney XIXth Scientific Research Meeting.

2001

  • Vaughan, C., Connor, M., Jennings, E., Marinelli, S., Christie, M., Allen, R. (2001). Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. The Journal of Physiology, 534, 849-859.
  • Jennings, E., Vaughan, C., Christie, M. (2001). Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. The Journal of Physiology, 534, 805-812.
  • Vaughan, C., Christie, M. (2001). Mechanisms of cannabinoid analgesia. In Franjo Grotenhermen (Hrsg) (Eds.), Cannabis and Cannabinoide, (pp. 109-119). Germany: Academic Press Elsevier.

To update your profile click here. For support on your academic profile contact .